Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
Respiratory therapist Marcy Freeman doesn't need a research study to confirm for her a return to...
Robert F Kennedy Jr, the US health secretary, on Sunday told American parents that they should...
Cases of cyclosporiasis, a parasitic infection known for causing explosive diarrhea, have now reached 47 states...
